xFOREST Therapeutics (Headquarter: Sakyo-ku, Kyoto, Japan) announced today that it has reached an agreement with Center for iPS Cell Research and Application, Kyoto University (Headquarter: Sakyo-ku, Kyoto, Japan) on a research collaboration.
About xFOREST Therapeutics
xFOREST Therapeutics Co., Ltd. is a Kyoto-based biotechnology company engaged in the research and development of RNA-targeted small-molecule medicines. Building on its proprietary RNA structure analysis technology, xFOREST discovers selective small molecules for RNA targets that protein-first discovery cannot reach, and advances them into drug programs with partners.